Endocrinology & Diabetes

SGLT2 Inhibitors (Gliflozins)

Indications and risks

This module is part of the members' library

Sign in to read the full teaching module, worked examples and end-of-module quiz.

Topics covered

Sglt2 Empagliflozin Dapagliflozin Heart Failure
Sign in to read this module

Full library access is £5 for 14 days. Free modules are available without a subscription.